Virginia Tech Researchers Identify Potential Breakthrough Molecule to Combat Glioblastoma Recurrence
A laboratory-designed molecule, developed and rigorously tested by a collaborative team of scientists at the Fralin Biomedical Research Institute at VTC, may offer a...
